AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.07B
1-Year Est. Return 86.9%
This Quarter Est. Return
1 Year Est. Return
+86.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$399M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
110
New
Increased
Reduced
Closed

Top Buys

1
+$56.3M
2
+$22.1M
3
+$20.3M
4
CYTK icon
Cytokinetics
CYTK
+$19.2M
5
APGE icon
Apogee Therapeutics
APGE
+$19.1M

Top Sells

1
+$32M
2
+$14.6M
3
+$11.2M
4
VERA icon
Vera Therapeutics
VERA
+$7.02M
5
INZY
Inozyme Pharma
INZY
+$7M

Sector Composition

1 Healthcare 91.07%
2 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTX icon
76
Context Therapeutics
CNTX
$98.3M
$390K 0.03%
402,653
-115,372
RPTX icon
77
Repare Therapeutics
RPTX
$91.6M
$352K 0.03%
200,000
CBIO
78
Crescent Biopharma
CBIO
$239M
$214K 0.02%
17,998
-262,033
ADGM
79
Adagio Medical Holdings
ADGM
$20.6M
$155K 0.01%
80,000
QTTB icon
80
Q32 Bio
QTTB
$47M
$55K ﹤0.01%
27,777
SPRY icon
81
ARS Pharmaceuticals
SPRY
$929M
$25.1K ﹤0.01%
+2,500
RCKTW icon
82
Rocket Pharmaceuticals Warrant
RCKTW
$3.6M
$2.99K ﹤0.01%
75,000
ABUS icon
83
Arbutus Biopharma
ABUS
$810M
– –
0
ALT icon
84
Altimmune
ALT
$514M
– –
0
AMGN icon
85
Amgen
AMGN
$182B
– –
0
AXSM icon
86
Axsome Therapeutics
AXSM
$7.51B
– –
-50,000
BPMC
87
DELISTED
Blueprint Medicines
BPMC
– –
-250,000
CAPR icon
88
Capricor Therapeutics
CAPR
$304M
– –
0
CRSP icon
89
CRISPR Therapeutics
CRSP
$4.97B
– –
0
EXEL icon
90
Exelixis
EXEL
$11.6B
– –
0
GALT icon
91
Galectin Therapeutics
GALT
$355M
– –
0
IMTXW
92
DELISTED
Immatics N.V. Warrants
IMTXW
– –
-187,204
INMB icon
93
INmune Bio
INMB
$41.5M
– –
0
INZY
94
DELISTED
Inozyme Pharma
INZY
– –
-1,749,359
KPTI icon
95
Karyopharm Therapeutics
KPTI
$98M
– –
0
MIRM icon
96
Mirum Pharmaceuticals
MIRM
$3.6B
– –
-24,692
NKTX icon
97
Nkarta
NKTX
$129M
– –
-800,000
NTLA icon
98
Intellia Therapeutics
NTLA
$975M
– –
0
NVAX icon
99
Novavax
NVAX
$1.09B
– –
0
OMER icon
100
Omeros
OMER
$686M
– –
0
1 2 3
4
5